Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with adenocarcinoma (a specific type of cancer) of the colon
- People whose cancer has not spread to nearby lymph nodes or other parts of the body (classified as Stage II)
- People whose cancer can be surgically removed
- People who are mentally able to understand the treatment plan and agree to take part in writing
- People whose kidney function meets a minimum threshold, based on blood test results (confirm with trial site)
- People whose liver function meets a minimum threshold, based on bilirubin levels in the blood — an exception may apply for people with a condition called Gilbert's disease (confirm with trial site)
- People whose blood platelet count, red blood cell levels, and white blood cell levels meet minimum thresholds, based on blood tests (confirm with trial site)
- People whose blood clotting levels fall within an acceptable range, based on a test called INR (confirm with trial site)
- People who do not have issues with alcohol or drug misuse
- People who are not currently enrolled in another clinical trial that would interfere with this one
- People who are not currently receiving ongoing immune therapy, chemotherapy, or hormone therapy
- People who do not have severe failure of any major organ
- People who are not pregnant or breastfeeding
- People who are using adequate contraception, if they are able to have children
- People who have provided written consent to participate
Who may not be able to join:
- People whose cancer has spread to lymph nodes or to other parts of the body
- People whose cancer cannot be surgically removed
- People whose general health and physical ability fall below a certain level, measured using a standard health scoring tool called the Karnofsky index (confirm with trial site)
- People who have a known allergy to iodine-containing substances or to products that contain human albumin
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +32(0)93326251
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Tumor status of the sentinel lymph node (SLN) and other lymph nodes (LN's)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.